Additional file 5 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis

Additional file 5: Table S2. Information of each included study for meta-analysis between landmark and surveillance strategy. Abbreviations: TP, true positive; FP, false positive; FN, false negative; TN, true negative. *: After excluding patients with small-cell lung cancer, the data for Chaudhuri AA 2017 changed to: landmark: TP = 17, TN = 0, FN = 1, TN = 16; surveillance: TP = 8, TN = 0, FN = 0, TN = 8. ψ: Patients who have been reported in Chaudhuri AA 2017 were excluded. ξ: After using 2 h after surgery as preferred landmark in Peng M 's study, the landmark results changed to: TP = 13, FP = 5, FN = 15, TN = 36.附加文件5：表S2。用于界标策略与监测策略间荟萃分析的各项纳入研究信息。缩略语：TP：真阳性（true positive）；FP：假阳性（false positive）；FN：假阴性（false negative）；TN：真阴性（true negative）。*：在剔除小细胞肺癌患者后，Chaudhuri AA 2017年研究的数据调整如下：界标组：TP=17，TN=0，FN=1，TN=16；监测组：TP=8，TN=0，FN=0，TN=8。ψ：已排除Chaudhuri AA 2017年研究中报道的患者。ξ：在Peng M的研究中将术后2小时作为首选界标后，界标分析结果调整为：TP=13，FP=5，FN=15，TN=36。